Media coverage about UnitedHealth Group (NYSE:UNH) has trended positive recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. UnitedHealth Group earned a media sentiment score of 2.34 on their scale. InfoTrie also assigned news stories about the healthcare conglomerate an news buzz score of 10 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock’s share price in the immediate future.
Here are some of the headlines that may have impacted UnitedHealth Group’s ranking:
- Nation’s biggest health insurer wades into the ‘Medicare for all’ fight (latimes.com)
- UnitedHealth CEO bashes Medicare-for-all on earnings call (bizjournals.com)
- How to Trade UnitedHealth Stock After Earnings Volatility (thestreet.com)
- UnitedHealth stock falls despite earnings beat, signaling investor jitters over ‘Medicare for All’ (finance.yahoo.com)
- UnitedHealth beats expectations all around (union-bulletin.com)
A number of research firms have commented on UNH. Stephens began coverage on UnitedHealth Group in a report on Monday, January 14th. They issued an “overweight” rating and a $287.00 target price for the company. ValuEngine lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, February 27th. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $279.00 target price for the company in a report on Saturday, January 5th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $310.00 price objective on shares of UnitedHealth Group in a report on Tuesday, January 15th. Finally, Credit Suisse Group reaffirmed a “buy” rating and issued a $310.00 price objective on shares of UnitedHealth Group in a report on Friday, February 8th. Three research analysts have rated the stock with a hold rating and twenty have assigned a buy rating to the stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $297.80.
Shares of UNH opened at $220.96 on Wednesday. The company has a debt-to-equity ratio of 0.64, a current ratio of 0.73 and a quick ratio of 0.73. UnitedHealth Group has a one year low of $215.82 and a one year high of $287.94. The firm has a market capitalization of $214.19 billion, a P/E ratio of 17.16, a PEG ratio of 1.14 and a beta of 0.79.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $3.73 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.60 by $0.13. UnitedHealth Group had a return on equity of 24.38% and a net margin of 5.30%. The company had revenue of $60.30 billion during the quarter, compared to analyst estimates of $59.72 billion. During the same quarter in the previous year, the company posted $3.04 earnings per share. UnitedHealth Group’s revenue was up 9.2% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group will post 14.62 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a yield of 1.63%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is presently 27.95%.
In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction dated Tuesday, January 22nd. The stock was sold at an average price of $266.61, for a total transaction of $1,333,050.00. Following the completion of the sale, the director now owns 77,702 shares of the company’s stock, valued at $20,716,130.22. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Richard T. Burke sold 15,000 shares of the business’s stock in a transaction dated Thursday, January 17th. The shares were sold at an average price of $260.55, for a total value of $3,908,250.00. Following the sale, the director now directly owns 193,872 shares of the company’s stock, valued at approximately $50,513,349.60. The disclosure for this sale can be found here. Insiders have sold 32,930 shares of company stock valued at $8,495,383 in the last three months. 0.87% of the stock is currently owned by corporate insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Article: What are the FAANG Stocks?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.